[Progress in the field of drug development. 17].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D000962:Antimalarials / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy; D002490:Central Nervous System / Q000187:drug effects; D002626:Chemistry, Pharmaceutical; D003278:Contraceptives, Oral, Hormonal / Q000494:pharmacology; D003287:Contrast Media; D005100:Expectorants / Q000494:pharmacology; D005493:Folic Acid Antagonists; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D004364:Pharmaceutical Preparations; D011804:Quinolines / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000935:Antifungal Agents; D000962:Antimalarials; D014150:Antipsychotic Agents; D000998:Antiviral Agents; D003278:Contraceptives, Oral, Hormonal; D003287:Contrast Media; D005100:Expectorants; D005493:Folic Acid Antagonists; D006634:Histamine H1 Antagonists; D006728:Hormones; D004364:Pharmaceutical Preparations; D011804:Quinolines; D014149:Tranquilizing Agents; D007987:Gonadotropin-Releasing Hormone; D007372:Interferons
Fortschritte auf dem Gebiet der Arzneimittelentwicklung. Teil 17.